Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Lexagene Holdings Inc V.LXG


Primary Symbol: LXXGQ

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.


GREY:LXXGQ - Post by User

Post by iamjunobazon May 20, 2020 5:39am
249 Views
Post# 31049957

Lexagene Potential Monthly Income From Test Sales

Lexagene Potential Monthly Income From Test Sales
Lexagene Potential Monthly Income From Test Sales
 
When Lexagene get 50 machines into the market running, let’s say 6 tests a day per machine for let’s say 25 days a month, this would equate to a total of circa 7500 tests per month being carried out across those machines 
 
50x6x25=7500 potential tests a month from 50 sold LX Analysers 
 
 
Monthly Income stream based at $ per test:
 
$50x7500  =$375,000 per month
 
$75x7500. =$562,500 per month
 
$100x7500 =$750,000 per month
 
As we know the above income is almost all straight to the bottom line as the test cartridges only cost $3-4 each to produce 
 
If an adopter ordered say 200 machines (large Veterinary group etc) that would create an income stream per month of $1.5 million at the lower end ($50 per test) and $3.0 million per month at the higher end ($100 per test)
 
To me it doesn’t look like Lexagene need to put many LX Analysers into the market to become a cash printing machine  
 
Also if you have a business where you need to carry out 150 tests a month then I guess this is going to easily cost you a $100 a test anyway plus the associated delays in sending out to a laboratory. Looking at different commercial tests they seem to range from $50-$250 depending on requirements. With the Lexagene test you are getting results for all 27 pathogens plus antibiotic resistance results at your finger tips,seems like a win,win situation for the user 
 
Once Lexagene reach a total of 500 machines in the market place on the above model based at $50 per test this would give an income of $3,750,000 per month with 1000 machines producing $7,500,000 per month  
 
Are my numbers right,any thoughts on this level on income and potential 
 
What do you think a reasonable sales target for LX Analysers will be in years 1,2,3 
 
Genmark have a market cap ranging between $700-$800 million dollars and appear to be losing millions a year as their own test costs are way to expensive ($50 a test to produce I believe) due to the way their machine runs. 
 
 
Lexagene Potential Monthly Income From Test Sales
 
When Lexagene get 50 machines into the market running, let’s say 6 tests a day per machine for let’s say 25 days a month, this would equate to a total of circa 7500 tests per month being carried out across those machines 
 
50x6x25=7500 potential tests a month from 50 sold LX Analysers 
 
 
Monthly Income stream based at $ per test:
 
$50x7500  =$375,000 per month
 
$75x7500. =$562,500 per month
 
$100x7500 =$750,000 per month
 
As we know the above income is almost all straight to the bottom line as the test cartridges only cost $3-4 each to produce 
 
If an adopter ordered say 200 machines (large Veterinary group etc) that would create an income stream per month of $1.5 million at the lower end ($50 per test) and $3.0 million per month at the higher end ($100 per test)
 
To me it doesn’t look like Lexagene need to put many LX Analysers into the market to become a cash pri Potential Monthly Income From Test Sales
 
When Lexagene get 50 machines into the market running, let’s say 6 tests a day per machine for let’s say 25 days a month, this would equate to a total of circa 7500 tests per month being carried out across those machines 
 
50x6x25=7500 potential tests a month from 50 sold LX Analysers 
 
 
Monthly Income stream based at $ per test:
 
$50x7500  =$375,000 per month
 
$75x7500. =$562,500 per month
 
$100x7500 =$750,000 per month
 
As we know the above income is almost all straight to the bottom line as the test cartridges only cost $3-4 each to produce 
 
If an adopter ordered say 200 machines (large Veterinary group etc) that would create an income stream per month of $1.5 million at the lower end ($50 per test) and $3.0 million per month at the higher end ($100 per test)
 
To me it doesn’t look like Lexagene need to put many LX Analysers into the market to become a cash printing machine  
 
Also if you have a business where you need to carry out 150 tests a month then I guess this is going to easily cost you a $100 a test anyway plus the associated delays in sending out to a laboratory. Looking at different commercial tests they seem to range from $50-$250 depending on requirements. With the Lexagene test you are getting results for all 27 pathogens plus antibiotic resistance results at your finger tips,seems like a win,win situation for the user 
 
Once Lexagene reach a total of 500 machines in the market place on the above model based at $50 per test this would give an income of $3,750,000 per month with 1000 machines producing $7,500,000 per month  
 
Are my numbers right,any thoughts on this level on income and potential 
 
What do you think a reasonable sales target for LX Analysers will be in years 1,2,3 
 
Genmark have a market cap ranging between $700-$800 million dollars and appear to be losing millions a year as their own test costs are way to expensive ($50 a test to produce I believe) due to the way their machine runs. 
 
 
Lexagene Potential Monthly Income From Test Sales
 
When Lexagene get 50 machines into the market running, let’s say 6 tests a day per machine for let’s say 25 days a month, this would equate to a total of circa 7500 tests per month being carried out across those machines 
 
50x6x25=7500 potential tests a month from 50 sold LX Analysers 
 
 
Monthly Income stream based at $ per test:
 
$50x7500  =$375,000 per month
 
$75x7500. =$562,500 per month
 
$100x7500 =$750,000 per month
 
As we know the above income is almost all straight to the bottom line as the test cartridges only cost $3-4 each to produce 
 
If an adopter ordered say 200 machines (large Veterinary group etc) that would create an income stream per month of $1.5 million at the lower end ($50 per test) and $3.0 million per month at the higher end ($100 per test)
 
To me it doesn’t look like Lexagene need to put many LX Analysers into the market to become a cash pri
<< Previous
Bullboard Posts
Next >>